A scientific team at Barnsley Hospital and the University of Sheffield in the UK concluded that men with type 2 diabetes or the metabolic syndrome, or both, are prone to have low testosterone levels. If so, testosterone replacement therapy with a gel applied to the skin may improve their response to insulin and their sexual function, according to the results of a new clinical trial.
The study showed a statistically significant improvement in insulin sensitivity in testosterone-treated men at 6 and 12 months. Testosterone therapy also led to a significant improvement in the score on a standard assessment of erectile function after 6 and 12 months.
The study was presented at Endocrine Society’s annual meeting in San Francisco this week.
No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...